Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Observational Study to Evaluate Safety Profile of Flixotide 50 μg pMDI Treatment in Chinese Subjects With Asthma Aged 1-<4 Years

NCT03273946 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03273946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03273946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Observational Study to Evaluate Safety Profile of Flixotide 50 μg pMDI Treatment in Chinese Subjects With Asthma Aged 1-<4 Years
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
January 9, 2018
Completion date
September 27, 2018
Enrollment
158 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

asthma